Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| (NASDAQ: IMUX) | Delayed: 8.19 +0.63 (8.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.56 | 52 Week High | $ | |||
| Open | $7.63 | 52 Week Low | $ | |||
| Day High | $8.60 | P/E | N/A | |||
| Day Low | $7.47 | EPS | $ | |||
| Volume | 512,177 | |||||
